{
  "docId": "019de076-8cfe-74f8-8267-71bfaaa75a6b",
  "docSlug": "6f650cb16e144ff2cbcc39c10e5d03e1",
  "documentTitle": "23andMe | Investor Presentation Deck | 39 slides",
  "authorId": "23andme",
  "authorName": "23andMe",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 18,
  "pageCount": 39,
  "prevPage": 17,
  "nextPage": 19,
  "slideType": "traction",
  "function": "show_traction",
  "density": "dense",
  "nDataPoints": 3,
  "notes": "The slide uses a process flow to illustrate the speed of development, supported by heatmaps and a bar chart showing adverse event profiles.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-8cfe-74f8-8267-71bfaaa75a6b/18",
  "deckHref": "/decks/019de076-8cfe-74f8-8267-71bfaaa75a6b",
  "deckJsonHref": "/decks/019de076-8cfe-74f8-8267-71bfaaa75a6b.json",
  "deckAnchorHref": "/decks/019de076-8cfe-74f8-8267-71bfaaa75a6b#slide-18",
  "components": [
    {
      "bbox": {
        "h": 0.4,
        "w": 0.25,
        "x": 0.67,
        "y": 0.4
      },
      "kind": "chart",
      "text": "Investigator-assessed irAEs by dose level",
      "attrs": null,
      "subkind": "bar-horizontal",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "30ce6853-9427-40c8-bf7c-21636bc3fedd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.25,
        "x": 0.08,
        "y": 0.35
      },
      "kind": "chart",
      "text": "Heatmap of CTLA4 gene variants and disease risk",
      "attrs": null,
      "subkind": "heatmap",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6af5049e-b1a9-4ec3-9d2f-54dfa4219d1d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.76,
        "x": 0.12,
        "y": 0.22
      },
      "kind": "diagram",
      "text": "23andMe \"IO Signature\" -> 23ME-00610 Lead Asset -> Genomic data successfully predicted '610 AE Profile",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8ea32a1a-f6ca-4f78-b1c2-347488dd864b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.25,
        "x": 0.36,
        "y": 0.78
      },
      "kind": "list",
      "text": "Program initiated: 2016; Lead molecule generated by 23andMe; First human dosed: 2021",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bccfd968-f20e-4ccf-8af2-094452591c10",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.86,
        "x": 0.07,
        "y": 0.05
      },
      "kind": "title",
      "text": "SPEED: Our lead IO program progressed from discovery to the clinic in 5 years",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7b889207-5114-4066-a966-6535d83ca778",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Waterfall chart",
      "slug": "waterfall-chart",
      "agent": null,
      "layer": "slide",
      "matchId": "9765f7a1-f4e3-468a-aff4-e5ed14b9430c",
      "evidence": "chart/heatmap: Heatmap of CTLA4 gene variants and disease risk, chart/bar-horizontal: Investigator-assessed irAEs by dose level",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "process",
      "slug": null,
      "matchId": "2301e60d-0820-4a5c-a7a4-dc63a6532e24",
      "evidence": "The slide uses a three-step arrow flow to show the progression of the drug development program.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 39,
      "from": 9,
      "beatId": "93eec936-fceb-4bb2-ab9b-6265df978407",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Solution (Provide relief)",
      "beatSlug": "problem-agitate-solution-solution-provide-relief",
      "evidence": "Slides 9-39 present 23andMe's solution, including their therapeutic pipeline and approach",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}